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Fibroblast to myofibroblast differentiation on modified poly-L-lysine surfaces
Background
The foreign body response to implanted devices is responsible for 
encapsulation of the device1, often hindering its function for patients.
• Transforming growth factor β (TGF-β) is involved in fibrous capsule 
formation2,3
• TGF-β leads to the differentiation of fibroblasts into myofibroblasts.2,3 
Myofibroblasts secrete large amounts of collagen and express α-smooth 
muscle actin, a cytoskeletal protein that enables myofibroblasts to contract 
collagen to form a dense, acellular, fibrous capsule1
• TGF-β must be activated from its latent form (L-TGF-β) by MMPs
Material Modification 
NIH/3T3 – modified PLL cytocompatibility
Fibroblast to myofibroblast differentiation 
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• Materials B and D inhibited myofibroblast formation to a large extent when 
fibroblasts were stimulated with L-TGF-β
• Results suggest that longer carbon chains may be more influential than 
chemical end groups
• All materials tested were shown to be cytocompatible
• A better understanding of the differentiation process was achieved
Future work could include cell co-culture to investigate the influence of 
materials on fibroblasts in the presence of different cell types, and in vivo 
studies could eventually be conducted to evaluate material effects. 
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Mouse NIH-3T3 fibroblasts were stimulated in vitro with TGF-β and L-TGF-β, then stained for tubulin, α-smooth muscle actin, and 
nuclei. A control with no stimulation was also performed for each material.
2
6Reduce the thickness of the 
fibrous capsule formed in 
response to implanted devices. 
• Use MMP-inhibiting 
materials to impede cleavage 
of L-TGF-β to TGF-β in order 
to prevent fibroblast to 
myofibroblast differentiation
• Evaluate material 
characteristics to determine 
which factors influence this 
differentiation process
Fibroblasts were stimulated in vitro with TGF-β and L-TGF-β on modified PLL-coated 
surfaces. Viability > 70% indicates cytocompatibility. All samples are compared to a 
control of fibroblasts on tissue culture plastic in the presence of the indicated 
stimulant.  
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